How to buy ImpediMed shares | A$0.082
Own ImpediMed shares in just a few minutes.
We’re committed to our readers and editorial independence. We don’t compare all products in the market and may receive compensation when we refer you to our partners, but this does not influence our opinions or reviews. Learn more about Finder .
ImpediMed Limited is a medical devices business based in Australia. ImpediMed shares (IPD) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.082 – a decrease of 1.2% over the previous week. ImpediMed has a trailing 12-month revenue of around $5.7 million.
How to buy shares in ImpediMed
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for ImpediMed . Find the share by name or ticker symbol: IPD. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until ImpediMed reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $0.082, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of ImpediMed . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
🧪How we chose these brokersFor our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.
How has coronavirus impacted ImpediMed 's share price?
Since the stock market crash in March caused by coronavirus, ImpediMed 's share price has had significant negative movement.
Its last market close was $0.082, which is 21.90% down on its pre-crash value of $0.105 and 115.79% up on the lowest point reached during the March crash when the shares fell as low as $0.038.
If you had bought $1,000 worth of ImpediMed shares at the start of February 2020, those shares would have been worth $434.78 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $713.04.
ImpediMed share priceUse our graph to track the performance of IPD stocks over time.
ImpediMed shares at a glance
|Latest market close||AUDA$0.082|
|52-week range||AUDA$0.032 - AUDA$0.225|
|50-day moving average||AUDA$0.0718|
|200-day moving average||AUDA$0.0632|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||AUDA$-0.064|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy ImpediMed stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
ImpediMed price performance over time
|1 week (2020-10-12)||-1.20%|
|1 month (2020-09-18)||22.39%|
|3 months (2020-07-17)||20.59%|
|6 months (2020-04-17)||105.00%|
|1 year (2019-10-18)||-48.75%|
|2 years (2018-10-19)||-81.16%|
|3 years (2017-10-19)||-89.51%|
|5 years (2015-10-19)||-90.99%|
|Revenue TTM||$5.7 million|
|Gross profit TTM||$4.1 million|
|Return on assets TTM||-57.31%|
|Return on equity TTM||-99.09%|
|Market capitalisation||$83.1 million|
TTM: trailing 12 months
ImpediMed share dividends
We're not expecting ImpediMed to pay a dividend over the next 12 months.
Have ImpediMed 's shares ever split?
ImpediMed 's shares were split on a 102:100 basis on 31 May 2009. So if you had owned 100 shares the day before before the split, the next day you'd have owned 102 shares. This wouldn't directly have changed the overall worth of your ImpediMed shares – just the quantity. However, indirectly, the new 2% lower share price could have impacted the market appetite for ImpediMed shares which in turn could have impacted ImpediMed 's share price.
ImpediMed share price volatility
Over the last 12 months, ImpediMed 's shares have ranged in value from as little as $0.032 up to $0.225. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while ImpediMed 's is 2.2297. This would suggest that ImpediMed 's shares are significantly more volatile than the average for this exchange and represent a higher risk.
ImpediMed Limited, a medical software technology company, together with its subsidiaries, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. It offers SOZO, a noninvasive bioimpedance spectroscopy device for the detection of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company sells its devices to hospitals and clinics. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.
Frequently asked questions
Ask an Expert